Research and Markets (http://www.researchandmarkets.com/reports/c42721) has announced the addition of Financial Markets Research: Bausch & Lombs Contact Lens Solution Withdrawal - ReNu MultiPlus Likely to Struggle in Attempt to Regain Market Share to their offering.

In May 2006 Bausch & Lombs ReNu with MoistureLoc contact lens solution was permanently withdrawn from markets worldwide due to an outbreak of a fungal eye infection. For a large market player, the loss of a new revenue driver and the negative publicity surrounding the event is likely to have a significant impact on future success, as well as implications for other companies in the sector.

Scope of this title:

• This report analyzes the market outlook in the aftermath of the withdrawal of Bausch & Lombs ReNu with MoistureLoc contact lens solution
• The author interviewed eight optometrists from the US and the EU in the course of research

Highlights of this title:

• Bausch & Lombs explanation of the cause of infection is in line with suspicions of interviewed optometry experts that the revolutionary make-up of MoistureLocs formula made it susceptible to external factors that could elevate infection risk.
• Moving forward, US practitioners will likely put more emphasis on patient adherence to particular recommended brands, and patients are likely to be less price-sensitive, favoring competitors over Bausch & Lombs older contact lens solution, ReNu MultiPlus.
• Collateral damage to Bausch & Lombs eye care franchise in European markets is expected to be minimal.

Reasons to read this report:

• Understand the implications of Bausch & Lombs product recall through in-depth analysis based on interviews with leading experts
• Anticipate likely changes in the future market dynamics for contact lens solutions following the withdrawal of ReNu with MoistureLoc

The contents inside this report include:

Summary

ReNu with MoistureLoc is dead

ReNu MultiPlus likely to struggle in attempt to regain market share

Bausch & Lomb and Renu

Background

Fusarium Keratitis

Overview

Renu Outlook

Experts are confident that increased incidence of infections is not a coincidence

MoistureLoc formula assumed be at fault, rather than contamination

US contact wearers appear deeply concerned

distrust spreads to all ReNu products

ReNu MultiPlus is seen as inferior to competitors, likely to be an obstacle for planned marketing ramp-up

Physicians likely to emphasize patient compliance to recommended solution

Patients appear to associate infections with "ReNu"

BOLs other brands may be unaffected

Less collateral damage expected to ReNu MultiPlus outside of the US and Asia Pacific

Financial Impact

Overview

Appendix

Our Healthcare

Disclosure information

Ask the analyst

List of Tables

Table 1: 2005 - 2006 forecast for Bausch & Lombs lens care portfolio due to ReNu MoistureLoc recall

For more information visit http://www.researchandmarkets.com/reports/c42721

Source: Datamonitor